Tube Pharmaceuticals GmbH

Tube Pharmaceuticals GmbH was founded early 2011 in Austria to develop and commercialise new synthetic compound classes derived from natural products for cancer treatment. By combining the compounds with various targeting approaches the efficacy and safety profile of drug candidates is further enhanced. Tube Pharmaceuticals focuses on the preclinical and clinical development of own candidates. In addition, the company pursues an active partnering and licensing strategy to evaluate further conjugation options and leverage the full potential of its platform for drug development.